LONDON — One of Google’s sister companies will team up with pharmaceuticals firm GlaxoSmithKline to develop tiny implants that can tap nerves and change their electronic signals as a way of treating chronic illnesses. GSK and Verily Life Sciences, a subsidiary of Google parent company Alphabet, have agreed to create a new company known as
